Immunohistochemically detectable p53 and mdm-2 oncoprotein expression in colorectal carcinoma: prognostic significance
暂无分享,去创建一个
A. Bankfalvi | M. Tötsch | W. Böcker | K. Schmid | M. Nogler | D. Öfner | H. Maier | B. Riedmann | G. Winde | P. Holzberger | M. Tötsch
[1] A. Bankfalvi,et al. Wet autoclave pretreatment for antigen retrieval in diagnostic immunohistochemistry , 1994, The Journal of pathology.
[2] T. Soussi,et al. Multifactorial analysis of p53 alteration in human cancer: A review , 1994, International journal of cancer.
[3] A. Levine,et al. The 1993 Walter Hubert Lecture: the role of the p53 tumour-suppressor gene in tumorigenesis. , 1994, British Journal of Cancer.
[4] C. Cordon-Cardo,et al. p53 mutations in human bladder cancer: Genotypic versus phenotypic patterns , 1994, International journal of cancer.
[5] B. Vogelstein,et al. An evaluation of six antibodies for immunohistochemistry of mutant p53 gene product in archival colorectal neoplasms , 1994, The Journal of pathology.
[6] M. Hollstein,et al. Clinical implications of the p53 tumor-suppressor gene. , 1993, The New England journal of medicine.
[7] G. Nakagawara,et al. p53 immunoreaction in endoscopic biopsy specimens of colorectal cancer, and its prognostic significance. , 1993, British Journal of Cancer.
[8] K. Kinzler,et al. Clues to the pathogenesis of familial colorectal cancer. , 1993, Science.
[9] D. Page,et al. p53: the promising story continues to unfold. , 1993, Human pathology.
[10] A. Ghosh,et al. Prognostic significance of p53 overexpression in gastric and colorectal carcinoma. , 1992, British Journal of Cancer.
[11] P. Meltzer,et al. Amplification of a gene encoding a p53-associated protein in human sarcomas , 1992, Nature.
[12] A. Levine,et al. The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation , 1992, Cell.
[13] M. Oren,et al. Enhanced binding of a 95 kDa protein to p53 in cells undergoing p53‐mediated growth arrest. , 1992, The EMBO journal.
[14] J. Minna,et al. Expression of mutant p53 proteins in lung cancer correlates with the class of p53 gene mutation. , 1992, Oncogene.
[15] T. Iwama,et al. p53 gene mutations in colorectal tumors from patients with familial polyposis coli. , 1991, Cancer research.
[16] C. Purdie,et al. p53 expression in colorectal tumors. , 1991, The American journal of pathology.
[17] H. Mewes,et al. p53 in colorectal cancer: clinicopathological correlation and prognostic significance , 1991, British Journal of Cancer.
[18] B. Vogelstein,et al. p53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis. , 1990, Cancer research.
[19] W. Bodmer,et al. p53 mutations in colorectal cancer. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[20] B. Vogelstein,et al. A genetic model for colorectal tumorigenesis , 1990, Cell.
[21] A. Harris,et al. Increased expression of mutant forms of p53 oncogene in primary lung cancer , 1990, The Lancet.
[22] D. Karnad,et al. Test for H2-antagonist response in non-ulcer dyspepsia , 1990, The Lancet.
[23] D. Ledbetter,et al. Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas. , 1989, Science.
[24] Dan Steinberg,et al. Survival: A Supplementary Module for SYSTAT , 1989 .
[25] J. Cuzick,et al. The grading of rectal cancer: historical perspectives and a multivariate analysis of 447 cases , 1986, Histopathology.
[26] R. Weller,et al. International Histological Classification of Tumours , 1981 .
[27] Road,et al. The Spread of Rectal Cancer and its Effect on Prognosis , 1958, British Journal of Cancer.
[28] E. Kaplan,et al. Nonparametric Estimation from Incomplete Observations , 1958 .
[29] R. Mirimanoff,et al. Clinical implications of the p53 tumor-suppressor gene. , 1994, The New England journal of medicine.
[30] G. Thomas,et al. Association of p53 mutations with short survival in colorectal cancer. , 1994, Gastroenterology.
[31] B. Spiessl. TNM atlas : illustrated guide to the TNM/pTNM-classification of malignant tumours , 1989 .